LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE879.3530 (+3.53 %)
PREV CLOSE ( ) 849.35
OPEN PRICE ( ) 854.70
BID PRICE (QTY) 879.35 (468)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 258391
TODAY'S LOW / HIGH ( )851.00 882.00
52 WK LOW / HIGH ( )723.55 1090
NSE881.2531.5 (+3.71 %)
PREV CLOSE( ) 849.75
OPEN PRICE ( ) 853.70
BID PRICE (QTY) 881.25 (6656)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4311564
TODAY'S LOW / HIGH( ) 850.50 884.75
52 WK LOW / HIGH ( )723.65 1090
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Deshbandhu Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 6640 2323

Email info@lupinworld.com

Website www.lupinworld.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
08Aug Lupin reports 43% fall in Q1 consolida
Lupin has reported results for first quarter ended June 30, 2018.The com..
31Jul Lupin trades in green on the BSE
Lupin is currently trading at Rs. 825.60, up by 5.25 points or 0.64% fro..
30Jul Lupin gets approval from EDQM for Mand
Lupin has received European Directorate for the Quality of Medicines (ED..
30Jul Lupin moves up on getting approval fro
Lupin is currently trading at Rs. 820.90, up by 5.50 points or 0.67% fro..
30Jul Lupin informs about press release
Lupin has informed about press release titled ‘Lupin’s Mandideep facilit..
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit4294.813446.6
Gross Profit 5621.5 17939.3
Operating Profit 6738.822169.8
Net Sales 25791.1100881.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7782.25 (2.87%)
M.Cap (Rs. in Cr)16536.74
Astrazeneca Pharma I (BSE)
 1840.75 (7.63%)
M.Cap (Rs. in Cr)4601.88
Torrent Pharma (BSE)
 1766.70 (3.98%)
M.Cap (Rs. in Cr)29896.58
Alkem Laboratories (BSE)
 2091.95 (2.57%)
M.Cap (Rs. in Cr)25012.40
Coral Laboratories (BSE)
 517.25 (8.67%)
M.Cap (Rs. in Cr)184.79
Shareholding Pattern
PROMOTERS 47.01%
NON-INSTITUTION 15.1%
MUTUAL FUNDS/UTI 6.21%
FI/BANKS/INSURANCE 5.48%
GOVERNMENT 0.25%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.